周五交易时段，疫苗制造商诺瓦瓦克斯医药（Novavax，股票代码：NVAX）股价出现大幅下跌，盘中跌幅高达5.07%，引发市场广泛关注。
据《华盛顿邮报》报道，特朗普政府卫生官员计划将新冠疫苗与25名儿童死亡案例联系起来，这一消息成为引发诺瓦瓦克斯医药股价下跌的主要原因。该报道引发了市场对疫苗安全性的担忧，不仅影响了诺瓦瓦克斯医药，其他疫苗制造商的股价也受到波及。
报道称，这些发现似乎基于提交给联邦疫苗不良事件报告系统的信息，其中包含未经核实的疫苗副作用或不良反应报告。消息传出后，疫苗生产商Moderna股价下跌超过7%，辉瑞和诺瓦瓦克斯医药均下跌近3%。尽管美国卫生与公众服务部尚未对此事作出回应，但该报道已对疫苗股造成明显冲击，投资者对疫苗企业的未来前景表示担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.